----item----
version: 1
id: {DCD1E299-A59A-47ED-8EEF-7D299FF9FEBA}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Mergers and Acquisitions 2013
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Mergers and Acquisitions 2013
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: a1fcb0b4-4aab-4984-9ca0-370c1e940fc0

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1161

<p> <tbody> <tr> </tr> <tr> <td> <tbody> <tr> <td>The latest medtech deals, as and when it happens<a></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td><strong>M&amp;A 2013</strong></td> <td><a><strong>M&amp;A 2012</strong></a></td> <td><strong><a>M&amp;A 2011</a></strong></td> <td><strong><a>FREE TRIAL</a></strong></td> </tr> </tbody> </td> </tr> <tr> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> </tr> <tr> <td><div><a>Deals</a></div></td> <td><div><a>M&amp;A </a></div></td> <td><div><a>Financials</a></div></td> <td><div><a>Funding </a></div></td> <td><div><a>Legal</a></div></td> <td><div><a>Start-ups &amp; SMEs </a></div></td> <td><div><a>Market Monitor </a></div></td> <td><div><a>Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 29

Mergers and Acquisitions 2013
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 78516

<p><table> <tbody> <tr> </tr> <tr> <td colspan="8" scope="row" widtd="101"><table> <tbody> <tr> <td colspan="4" scope="row" widtd="101">The latest medtech deals, as and when it happens<a name="top" id="top"></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2012 so far. </td> </tr> <tr> <td bgcolor="#cccccc" scope="row" widtd="101"><strong>M&amp;A 2013</strong></td> <td bgcolor="#666666" scope="row" widtd="101"><a href="http://www.clinica.co.uk/MnA/_2012/" class="optionsLink"><strong>M&amp;A 2012</strong></a></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/_2011/" class="optionsLink">M&amp;A 2011</a></strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/freetrial/" class="optionsLink">FREE TRIAL</a></strong></td> </tr> </tbody> </table></td> </tr> <tr> <td><a href="http://www.clinica.co.uk/business/"><img src="-/media/A41DB0E6789340E3BBE2BB586EBE4293.ashx" alt="Deals" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/"><img src="-/media/1594690D6C314ABFA668C2F281D90DEC.ashx" alt="M&amp;A" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/financials/"><img src="-/media/873669F6772642DC9C0C091A39B44486.ashx" alt="Financials" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><div><a href="http://www.clinica.co.uk/business/funding/"><img src="-/media/B1AB1227A20C433897DB3C8B2F140E45.ashx" alt="Funding" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/legal/"><img src="-/media/7D0516FC157A4E1F896F543962188904.ashx" alt="Legal" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/start-upssmes/"><img src="-/media/66EE0878ED2E4CEC9D21449351C40077.ashx" alt="Start-ups &amp; SMEs" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/marketmonitor/"><img src="-/media/808B4B2204F542438455FA3DB83F4C28.ashx" alt="Market Monitor" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/ma2/"><img src="-/media/7183F022AB364B8C8C43E7EC13518288.ashx" alt="Google Map" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> </tr> <tr> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/" class="optionsLink">Deals</a></div></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/" class="optionsLink">M&amp;A </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/financials/" class="optionsLink">Financials</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/funding/" class="optionsLink">Funding </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/legal/" class="optionsLink">Legal</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/start-upssmes/" class="optionsLink">Start-ups &amp; SMEs </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/marketmonitor/" class="optionsLink">Market Monitor </a></div></td> <td><div><a href="http://www.clinica.co.uk/ma2/" class="optionsLink">Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody> </table> </p> <p><p> <table> <tr> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Acquirer </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Target </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Industry sector </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Price paid </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date announced </b> </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> <b>Date completed </b> </p> </th> </tr> <tr> <td> <p> <b>2013 </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> <td> <p> <b> </b> </p> </td> </tr> <tr> <td> <p> <b>December</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Patient Safety Technologies (US) </p> </td> <td> <p> Surgery safety systems </p> </td> <td> <p> $120m </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/surgicalwoundcare/Stryker-slips-in-fourth-purchase-before-year-end-349070">31/12/13</a> </p> </td> <td> <p> 24/3/14 </p> </td> </tr> <tr> <td> <p> <b>PTC (US)</b> </p> </td> <td> <p> ThingWorx (US) </p> </td> <td> <p> Internet platform for medical devices, telecommunications, agriculture </p> </td> <td> <p> $112m </p> </td> <td> <p> 30/12/13 </p> </td> <td> <p> 30/12/13 </p> </td> </tr> <tr> <td> <p> <b>Intrexon (US)</b> </p> </td> <td> <p> Medistem (US) </p> </td> <td> <p> Stem cells </p> </td> <td> <p> $26m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Intrexon-buys-Medistem-to-expand-regen-medicine-offerings-349000">24/12/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AtriCure (US)</b> </p> </td> <td> <p> Endoscopic Technologies (US) </p> </td> <td> <p> Surgical ablation </p> </td> <td> <p> 2.1 million Atricure shares ($34m) upfront, up to $26m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/AtriCure-fleshes-out-afib-portfolio-with-Estech-buy-348956">20/12/13</a> </p> </td> <td> <p> 2/1/14 </p> </td> </tr> <tr> <td> <p> <b>Valeant Pharmaceuticals (Canada)</b> </p> </td> <td> <p> Solta Medical (US) </p> </td> <td> <p> Aesthetics </p> </td> <td> <p> $250m plus $150m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Valeant-swallows-another-company-buys-Solta-for-250m-348921?autnID=/contentstore/clinica/codex/afcd9970-66fe-11e3-8f73-257c4a8c1054.xml">19/12/13</a> </p> </td> <td> <p> 23/1/14 </p> </td> </tr> <tr> <td> <p> <b>Compa&ntilde;&iacute;a Mexicana de Radiolog&iacute;a (Mexico)</b> </p> </td> <td> <p> Naviscan (US) </p> </td> <td> <p> Diagnostic imaging (positron emission mammography) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Mexicos-CMR-buys-Naviscans-assets-348793?autnID=/contentstore/clinica/codex/67c7b250-6664-11e3-8f73-257c4a8c1054.xml">16/12/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Mexicos-CMR-buys-Naviscans-assets-348793?autnID=/contentstore/clinica/codex/67c7b250-6664-11e3-8f73-257c4a8c1054.xml">16/12/13</a> </p> </td> </tr> <tr> <td> <p> <b>Alpha Imaging (US)</b> </p> </td> <td> <p> Tristar Midatlantic Imaging (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 11/12/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> Caesara Medical Electronics (Israel) </p> </td> <td> <p> Infusion pump systems </p> </td> <td> <p> $100m for 40% stake </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/CareFusion-gains-stake-in-Israeli-infusion-pump-developer-348716?autnID=/contentstore/clinica/codex/9ecb95c4-6273-11e3-8f73-257c4a8c1054.xml">11/12/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Calbiotech (US)</b> </p> </td> <td> <p> Moduline Systems (US) </p> </td> <td> <p> In vitro diagnostics (microplate-dispensing and vial-filling equipment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 10/12/13 </p> </td> <td> <p> 10/12/13 </p> </td> </tr> <tr> <td> <p> <b>Accelrys (US)</b> </p> </td> <td> <p> QUMAS (US) </p> </td> <td> <p> IT (cloud-based and on-premises compliance software) </p> </td> <td> <p> $50m </p> </td> <td> <p> 9/12/13 </p> </td> <td> <p> 9/12/13 </p> </td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> Given Imaging (Israel) </p> </td> <td> <p> Capsule endoscopy </p> </td> <td> <p> $860m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Growth-a-Given-Covidien-splashes-out-860m-on-PillCam-developer-348632?autnID=/contentstore/clinica/codex/e3befdb3-60c7-11e3-8f73-257c4a8c1054.xml">9/12/13</a> </p> </td> <td> <p> 27/2/14 </p> </td> </tr> <tr> <td> <p> <b>Getinge (Sweden)</b> </p> </td> <td> <p> Pulsion Medical Systems (Germany) </p> </td> <td> <p> Patient monitoring (hemodynamic monitoring) </p> </td> <td> <p> &euro;139.3m ($190) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Getinge-takes-step-closer-to-Pulsion-acquisition-348586?autnID=/contentstore/clinica/codex/dc2c3ad4-5e69-11e3-8f73-257c4a8c1054.xml">6/12/13</a> </p> </td> <td> <p> 20/2/14 </p> </td> </tr> <tr> <td> <p> <b>Konica Minolta (Japan)</b> </p> </td> <td> <p> Panasonic Healthcare's ultrasound business (Japan) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/12/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ResMed (US)</b> </p> </td> <td> <p> Unimedis (Czech Republic) </p> </td> <td> <p> Respiratory (treatment of sleep-disordered breathing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/12/13 </p> </td> <td> <p> 2/12/13 </p> </td> </tr> <tr> <td> <p> <b>HeartWare International (US)</b> </p> </td> <td> <p> CircuLite (US) </p> </td> <td> <p> Cardiovascular (circulatory support) </p> </td> <td> <p> $30m upfront, $320m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/HeartWare-pumps-up-with-Circulite-buy-348454">2/12/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/HeartWare-pumps-up-with-Circulite-buy-348454">2/12/13</a> </p> </td> </tr> <tr> <td> <p> <b>November</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Politec Sa&uacute;de (Brazil) </p> </td> <td> <p> Wound care distribution </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/SandN-makes-second-Brazilian-buy-this-year-348384">27/11/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Henry Schein (US)</b> </p> </td> <td> <p> 60% stake in BioHorizons (US) </p> </td> <td> <p> Dental implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 26/11/13 </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/business/manda/Henry-Schein-takes-a-bite-of-BioHorizons-349069">31/12/13</a> </p> </td> </tr> <tr> <td> <p> <b>Ansell (Australia)</b> </p> </td> <td> <p> BarrierSafe Solutions International (US) </p> </td> <td> <p> Single-use gloves </p> </td> <td> <p> $615m </p> </td> <td> <p> 26/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Apple (US)</b> </p> </td> <td> <p> PrimeSense (Israel) </p> </td> <td> <p> 3D motion-tracking technology </p> </td> <td> <p> $350m </p> </td> <td> <p> 25/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Dentsply International (US)</b> </p> </td> <td> <p> Triodent (New Zealand) </p> </td> <td> <p> Professional dental consumables used in restorative dentistry </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Dentsply International (US)</b> </p> </td> <td> <p> QAHR (Hong Kong) </p> </td> <td> <p> Dental implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/11/13 </p> </td> <td> <p> 22/11/13 </p> </td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> GE Healthcare's Vital Signs business (US) </p> </td> <td> <p> Respiratory care and anesthesia </p> </td> <td> <p> $500m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/GE-Healthcare-sells-Vital-Signs-to-CareFusion-at-a-discount-348198?autnID=/contentstore/clinica/codex/fc9a96d5-5067-11e3-8f73-257c4a8c1054.xml">18/11/13 </a> </p> </td> <td> <p> 31/12/13 </p> </td> </tr> <tr> <td> <p> <b>Grifols (Spain)</b> </p> </td> <td> <p> Novartis's blood transfusion diagnostics business (Switzerland) </p> </td> <td> <p> In vitro diagnostics (blood testing) </p> </td> <td> <p> $1.675bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/GrifolsNovartis-blood-testing-buy-to-up-Dx-revenue-five-fold-348023">11/11/13</a> </p> </td> <td> <p> 9/1/14 </p> </td> </tr> <tr> <td> <p> <b>Cantel Medical (US)</b> </p> </td> <td> <p> Jet Prep (Israel) </p> </td> <td> <p> Endoscopy (irrigation and aspiration cathethers) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> TempSys (US) </p> </td> <td> <p> Continuous monitoring </p> </td> <td> <p> $9.5m </p> </td> <td> <p> 6/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mesa Laboratories (US)</b> </p> </td> <td> <p> Amega Scientific (US) </p> </td> <td> <p> Continuous monitoring </p> </td> <td> <p> $12.3m upfront, up to $10m milestones </p> </td> <td> <p> 6/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Terumo BCT (US)</b> </p> </td> <td> <p> GADA Turkey (Turkey) </p> </td> <td> <p> Blood banking (components and equipment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/11/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>October</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Vidacare (US) </p> </td> <td> <p> Orthopedics (intraosseous access devices) </p> </td> <td> <p> $262.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Teleflex-inflates-portfolio-but-shrinks-FY13-revenue-prospects-yet-again-347728?autnID=/contentstore/clinica/codex/aaf407e8-4177-11e3-8f73-257c4a8c1054.xml">30/10/13</a> </p> </td> <td> <p> 2/12/13 </p> </td> </tr> <tr> <td> <p> <b>Apollo EndoSurgery (US)</b> </p> </td> <td> <p> Allergan's obesity business (US) </p> </td> <td> <p> Gastric bands and intragastric balloons </p> </td> <td> <p> $75m upfront, $15m stake in Allergan, $20m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Allergan-trims-off-fat-busting-portfolio-to-Apollo-347716?autnID=/contentstore/clinica/codex/893ab79b-40bd-11e3-8f73-257c4a8c1054.xml">30/10/13</a> </p> </td> <td> <p> 2/12/13 </p> </td> </tr> <tr> <td> <p> <b>Vention Medical (US)</b> </p> </td> <td> <p> Fast Forward Medical (US) </p> </td> <td> <p> Catheter-based devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/10/13 </p> </td> <td> <p> 29/10/13 </p> </td> </tr> <tr> <td> <p> <b>Integra Lifesciences (US)</b> </p> </td> <td> <p> Covidien's Confluent Surgical products (Ireland) </p> </td> <td> <p> Neurosurgery </p> </td> <td> <p> $235m upfront, $30m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Integra-looks-to-the-future-with-DuraSeal-buy-347684?autnID=/contentstore/clinica/codex/8f0ec6e9-4092-11e3-8f73-257c4a8c1054.xml">29/10/13</a> </p> </td> <td> <p> 15/1/14 </p> </td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> CLC Bio (Denmark) </p> </td> <td> <p> Bioinformatics for genome sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Bioinformatics-comes-further-into-spotlight-with-Illumina-Qiagen-buys-347674?autnID=/contentstore/clinica/codex/2167111e-4079-11e3-8f73-257c4a8c1054.xml">29/10/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> NextBio (US) </p> </td> <td> <p> Bioinformatics for genome sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Bioinformatics-comes-further-into-spotlight-with-Illumina-Qiagen-buys-347674?autnID=/contentstore/clinica/codex/2167111e-4079-11e3-8f73-257c4a8c1054.xml">29/10/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quidel (US)</b> </p> </td> <td> <p> AnDiaTec (Germany) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $2.6m upfront, $4.7m milestones </p> </td> <td> <p> 23/10/13 </p> </td> <td> <p> 23/10/13 </p> </td> </tr> <tr> <td> <p> <b>Union MedTech (UK)</b> </p> </td> <td> <p> Rex Bionics (New Zealand) </p> </td> <td> <p> Robotic exoskeletons </p> </td> <td> <p> 761m Union Medtech shares (equivalent to &pound;9.5m/$15.4m) </p> </td> <td> <p> 18/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Wright Medical (US)</b> </p> </td> <td> <p> Biotech International (France) </p> </td> <td> <p> Orthopedics (extremities) </p> </td> <td> <p> $75m upfront plus $5m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Wright-pads-out-extremities-347434">17/10/13</a> </p> </td> <td> <p> 15/11/13 </p> </td> </tr> <tr> <td> <p> <b>Brookhaven Medical (US)</b> </p> </td> <td> <p> Wound Management Technologies (US) </p> </td> <td> <p> Wound care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MedPlast (US)</b> </p> </td> <td> <p> Orthoplastics (UK) </p> </td> <td> <p> Orthopedics (materials) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/10/13 </p> </td> <td> <p> 14/10/13 </p> </td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> NanoStim (US) </p> </td> <td> <p> Cardiac rhythm management (leadless pacemaker) </p> </td> <td> <p> $123.5m upfront, $65m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/St-Jude-adds-to-portfolio-first-CE-marked-leadless-pacemaker-347304">14/10/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/St-Jude-adds-to-portfolio-first-CE-marked-leadless-pacemaker-347304">14/10/13</a> </p> </td> </tr> <tr> <td> <p> <b>Mesoblast (Australia)</b> </p> </td> <td> <p> Osiris Therapeutics' stem cell technology (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> $35m cash and $15m stock upfront, up to $50m milestones </p> </td> <td> <p> <a href="$35m cash and $15m stock upfront, up to $50m milestones">14/10/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hybrigenics (France)</b> </p> </td> <td> <p> Genomic activities of Imaxio (France) </p> </td> <td> <p> Molecular diagnostics (DNA and RNA sequencing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 11/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> ConVerge Diagnostic Services (US) </p> </td> <td> <p> Diagnostic lab services (cytology and pathology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/One-in-one-out-Quest-continues-reshaping-of-operations-347122">9/10/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Laborie Medical Technologies (Canada)</b> </p> </td> <td> <p> UroMed Technology (US) </p> </td> <td> <p> Electrical stimulation devices (for pelvic floor rehab treating urinary and fecal incontinence) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 8/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Biomet (US)</b> </p> </td> <td> <p> Lanx (US) </p> </td> <td> <p> Orthopedics (spine) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Biomet-acquires-spine-specialist-as-Q1-hip-and-knee-momentum-improves-347105">8/10/13 </a> </p> </td> <td> <p> 1/11/13 </p> </td> </tr> <tr> <td> <p> <b>Merit Medical (US)</b> </p> </td> <td> <p> Datascope's pressure assisted devices, Safeguard and Air-Band (US) </p> </td> <td> <p> Hemostatic devices for use during surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 7/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Merit Medical (US)</b> </p> </td> <td> <p> Radial Assist (US) </p> </td> <td> <p> Surgery (products to stabilize patients' arms during radial artery access procedures) </p> </td> <td> <p> $2.5m </p> </td> <td> <p> 7/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> InnoLap Surgical (Israel) </p> </td> <td> <p> Minimally-invasive surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Teleflex-gets-more-scarless-surgery-tech-with-InnoLap-buy-347026">3/10/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MAKO Surgical (US)</b> </p> </td> <td> <p> Pipeline Biomedical (US) </p> </td> <td> <p> Orthopedics/robotic surgery </p> </td> <td> <p> $2.5m plus 3.95m MAKO shares </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/MAKO-buys-partner-Pipeline-as-Stryker-deal-fuels-further-acquisition-rumors-347030">3/10/13</a> </p> </td> <td> <p> 8/10/13 </p> </td> </tr> <tr> <td> <p> <b>Vikon Surgical (US)</b> </p> </td> <td> <p> Alpha Med-Surge's ONE Technology and ONE HEADLIT surgical headlight (US) </p> </td> <td> <p> Surgery </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Electrical Geodesics (US)</b> </p> </td> <td> <p> Avatar EEG Solutions (Canada) </p> </td> <td> <p> Neurology (EEG recording for research) </p> </td> <td> <p> $325,000 </p> </td> <td> <p> 1/10/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Clinical Genomics Technologies (Australia)</b> </p> </td> <td> <p> Quest Diagnostics' Enterix colorectal cancer screening business (US) </p> </td> <td> <p> Diagnostic lab </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/10/13 </p> </td> <td> <p> 30/9/13 </p> </td> </tr> <tr> <td> <p> <b>September</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Ulco Medical (Australia) </p> </td> <td> <p> Patient monitoring and life support </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> September 2013 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>KKR (US)</b> </p> </td> <td> <p> Panasonic Healthcare (Japan) </p> </td> <td> <p> IVDs, healthcare IT and biomedical equipment </p> </td> <td> <p> &yen;165bn ($1.67bn) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Panasonic-Healthcare-gets-1.7bn-private-equity-buyer-346931?autnID=/contentstore/clinica/codex/f1e8020a-29b5-11e3-8964-4d1e910a64a6.xml">30/9/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medivo (US)</b> </p> </td> <td> <p> GExperts' OnTrack Diabetes app (US) </p> </td> <td> <p> Diabetes (app for tracking data) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 26/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> MAKO Surgical (US) </p> </td> <td> <p> Robotic surgery </p> </td> <td> <p> $1.65bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Stryker-bets-big-bucks-on-robotic-surgery-with-MAKO-buy-346855">26/9/13</a> </p> </td> <td> <p> 17/12/13 </p> </td> </tr> <tr> <td> <p> <b>Biosearch Technologies (US)</b> </p> </td> <td> <p> Majority stake in LightSpeed Genomics (US) </p> </td> <td> <p> In vitro diagnostics (optical detection technology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 25/9/13 </p> </td> <td> <p> 25/9/13 </p> </td> </tr> <tr> <td> <p> <b>Sysmex (Japan)</b> </p> </td> <td> <p> Partec (Germany) </p> </td> <td> <p> In vitro diagnostics (flow cytometry) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sysmex (Japan)</b> </p> </td> <td> <p> Indivumed's Inostics and Inostics Inc subsidiaries (Germany, US) </p> </td> <td> <p> In vitro diagnostics (DNA-based cancer diagnostics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>SkylineDx (the Netherlands)</b> </p> </td> <td> <p> Assets of Skyline Diagnostics (the Netherlands) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 24/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Greenway Medical Technologies (US)</b> </p> </td> <td> <p> Vitera Healthcare Solutions (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $644m </p> </td> <td> <p> 23/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>IXICO (UK)</b> </p> </td> <td> <p> Phytopharm (UK) </p> </td> <td> <p> Diagnostics (diagnosis of dementia for clinical trials and clinical use) </p> </td> <td> <p> Share-based deal worth around &pound;5.6m ($9.0m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/IXICO-gets-public-vehicle-with-Phytopharm-reverse-takeover-346776?autnID=/contentstore/clinica/codex/2dccdef4-2463-11e3-8964-4d1e910a64a6.xml">23/9/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Analogic (US)</b> </p> </td> <td> <p> Remaining ownership stake in PocketSonics (US) </p> </td> <td> <p> Ultrasound </p> </td> <td> <p> $11m, up to $3m milestones </p> </td> <td> <p> 20/9/13 </p> </td> <td> <p> 20/9/13 </p> </td> </tr> <tr> <td> <p> <b>Eckert &amp; Ziegler (Germany)</b> </p> </td> <td> <p> BTG's brachytherapy business (US) </p> </td> <td> <p> Brachytherapy </p> </td> <td> <p> $5m plus 30% share of sales for 12 months </p> </td> <td> <p> 17/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Golden Equity/ CoorsTek Medical (US)</b> </p> </td> <td> <p> Innovative Medical Device Solutions (US) </p> </td> <td> <p> Orthopedics (contract manufacturing of medical implants and instruments) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bruker (US)</b> </p> </td> <td> <p> Prairie Technologies (US) </p> </td> <td> <p> Instrumentation (multiphoton fluorescence microscopy) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> FlowSense (Israel) </p> </td> <td> <p> Renal (urine output monitoring) </p> </td> <td> <p> $9.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Baxter-still-shopping-as-Gambro-deal-closes-346490">11/9/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Enzymatics (US)</b> </p> </td> <td> <p> ArcherDx (US) </p> </td> <td> <p> Next-generation sequencing </p> </td> <td> <p> Up to $50m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Wilex-and-ArcherDx-deals-see-IVD-consolidation-continue-346443">9/9/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Wilex-and-ArcherDx-deals-see-IVD-consolidation-continue-346443">9/9/13</a> </p> </td> </tr> <tr> <td> <p> <b>Nuclea Biotechnologies (US)</b> </p> </td> <td> <p> Wilex's US subsidiary (US) </p> </td> <td> <p> Companion diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Wilex-and-ArcherDx-deals-see-IVD-consolidation-continue-346443">9/9/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MedSolutions (US)</b> </p> </td> <td> <p> Triad (US) </p> </td> <td> <p> Musculoskeletal products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/9/13 </p> </td> <td> <p> 19/11/13 </p> </td> </tr> <tr> <td> <p> <b>bioMérieux (France)</b> </p> </td> <td> <p> BioFire Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $450m plus debt </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/bioMerieux-bulks-up-with-BioFire---but-at-too-high-a-price-346282?autnID=/contentstore/clinica/codex/85a33377-157c-11e3-a0c4-29b88c5f8c92.xml">5/9/13</a> </p> </td> <td> <p> 16/1/14 </p> </td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> Rochester Medical (US) </p> </td> <td> <p> Urology homecare </p> </td> <td> <p> $262m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/CR-Bard-sharpens-high-growth-focus-with-Rochester-buy-346288?autnID=/contentstore/clinica/codex/f2e8e4b8-160a-11e3-a0c4-29b88c5f8c92.xml">5/9/13</a> </p> </td> <td> <p> 14/11/13 </p> </td> </tr> <tr> <td> <p> <b>Advance Medical (US)</b> </p> </td> <td> <p> Imunotech Sistemas Diagnosticos (Brazil) </p> </td> <td> <p> Distribution of medical and lab equipment and reagents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Agilent (US)</b> </p> </td> <td> <p> Assets from ABC Instrumentacion Analitica (Mexico) </p> </td> <td> <p> Distribution of analytical solutions </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LabCorp (US)</b> </p> </td> <td> <p> John Muir Health's clinical laboratory outreach business (US) </p> </td> <td> <p> Lab services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/9/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Nikkiso (Japan)</b> </p> </td> <td> <p> Baxter's continuous renal replacement therapy (CRRT) business (US) </p> </td> <td> <p> Acute kidney injury treatment </p> </td> <td> <p> Undisclosed, thought to be &yen;3.8bn ($36.3m) </p> </td> <td> <p> 3/9/13 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Baxter-completes-renal-replacement-sell-off-to-make-room-for-Gambro-349162?autnID=/contentstore/clinica/codex/f180f7c2-77af-11e3-8f73-257c4a8c1054.xml">7/1/14</a> </p> </td> </tr> <tr> <td> <p> <b>August</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>ITC Nexus Holding (US)</b> </p> </td> <td> <p> Accumetrics (US) </p> </td> <td> <p> In vitro diagnostics (assessing response to antiplatelet therapies) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 30/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LeMaitre Vascular (US)</b> </p> </td> <td> <p> InaVein (MA) </p> </td> <td> <p> Treatment of vein disorders </p> </td> <td> <p> $2.5m </p> </td> <td> <p> 28/8/13 </p> </td> <td> <p> 28/8/13 </p> </td> </tr> <tr> <td> <p> <b>Volcano (US)</b> </p> </td> <td> <p> Medtronic's Pioneer Plus transducer and catheter (US) </p> </td> <td> <p> Peripheral vascular treatment </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Volcano-expands-therapeutic-offering-with-Medtronics-Pioneer-Plus-346050?autnID=/contentstore/clinica/codex/61bd8ce3-0f1c-11e3-a0c4-29b88c5f8c92.xml">27/8/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Response Genetics (US)</b> </p> </td> <td> <p> All assets of Pathwork Diagnostics (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $200,000 cash and 500,000 shares </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Good-Response-as-it-scoops-up-Pathwork-346043?autnID=/contentstore/clinica/codex/74bb9142-0f01-11e3-a0c4-29b88c5f8c92.xml">27/8/13</a> </p> </td> <td> <p> 27/8/13 </p> </td> </tr> <tr> <td> <p> <b>BioReference Laboratories (US)</b> </p> </td> <td> <p> Edge BioSystems CLIA laboratory business and related assets (US) </p> </td> <td> <p> Genetic sequencing services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> Medafor (US) </p> </td> <td> <p> Wound care (hemostatic agents) </p> </td> <td> <p> $200m upfront, $80m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/When-the-going-gets-tough-Bard-goes-shopping-345950?autnID=/contentstore/clinica/codex/156b45c6-098c-11e3-a0c4-29b88c5f8c92.xml">20/8/13</a> </p> </td> <td> <p> 4/10/13 </p> </td> </tr> <tr> <td> <p> <b>St Jude Medical (US)</b> </p> </td> <td> <p> Endosense (Switzerland) </p> </td> <td> <p> Cardiology (force-sensing catheter ablation technologies) </p> </td> <td> <p> CHF159m ($170m) upfront, CHF150m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/St-Jude-ends-MandA-dry-spell-with-force-sensing-heart-ablation-tech-buy-345936?autnID=/contentstore/clinica/codex/bc64680a-08e0-11e3-a0c4-29b88c5f8c92.xml">19/8/13</a> </p> </td> <td> <p> 19/8/13 </p> </td> </tr> <tr> <td> <p> <b>SafeStich Medical (US)</b> </p> </td> <td> <p> TransEnterix (US) </p> </td> <td> <p> Minimally-invasive surgery/robotic surgery </p> </td> <td> <p> Undisclosed (share-based merger) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/SafeStitch-and-TransEnterix-merge-to-push-robotic-surgery-technologies-345892?autnID=/contentstore/clinica/codex/44308b89-05ad-11e3-a0c4-29b88c5f8c92.xml">15/8/13</a> </p> </td> <td> <p> 15/8/13 </p> </td> </tr> <tr> <td> <p> <b>Quintiles (US)</b> </p> </td> <td> <p> Novella Clinical (US) </p> </td> <td> <p> Clinical research organization for oncology, medical devices and diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/8/13 </p> </td> <td> <p> 16/9/13 </p> </td> </tr> <tr> <td> <p> <b>BGS Acquisition (US)</b> </p> </td> <td> <p> TransnetYX (US) </p> </td> <td> <p> Genotyping for research </p> </td> <td> <p> 8m BGS shares plus up to $15m cash, plus up to 8m share earnout </p> </td> <td> <p> 14/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Metamark Genetics (US)</b> </p> </td> <td> <p> Endo Health Solutions' HealthTronics Laboratory Solutions (US) </p> </td> <td> <p> Anatomical pathology services for urologists </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Endo-offloads-pathology-biz-to-Metamark-as-restructuring-continues-345866?autnID=/contentstore/clinica/codex/806bc0c3-04d4-11e3-a0c4-29b88c5f8c92.xml">14/8/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Cardiocom (US) </p> </td> <td> <p> Telehealth </p> </td> <td> <p> $200m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Medtronic-builds-in-house-telehealth-capability-with-Cardiocom-buy-345827?autnID=/contentstore/clinica/codex/a2bd986a-0353-11e3-a0c4-29b88c5f8c92.xml">12/8/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Gene by Gene (US)</b> </p> </td> <td> <p> Arpeggi (US) </p> </td> <td> <p> Bioinformatics for genome sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Gene-by-Gene-boosts-genome-sequencing-with-Arpeggi-buy-345782?autnID=/contentstore/clinica/codex/3df6b4fc-0032-11e3-a0c4-29b88c5f8c92.xml">9/8/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Undisclosed</b> </p> </td> <td> <p> Invacare's Champion Manufacturing unit (US) </p> </td> <td> <p> Medical chairs for dialysis procedures </p> </td> <td> <p> $45m </p> </td> <td> <p> 7/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Source BioScience (UK)</b> </p> </td> <td> <p> Vindon (UK) </p> </td> <td> <p> Environmental control products for the pharma, life sciences and food industries </p> </td> <td> <p> &pound;12.2m ($18.9m) </p> </td> <td> <p> 7/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Juniper Investment (US)</b> </p> </td> <td> <p> Theragenics (US) </p> </td> <td> <p> Prostate cancer therapy (surgery and brachytherapy) </p> </td> <td> <p> $68m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Theragenics-up-again-as-Juniper-agrees-to-buy-345659?autnID=/contentstore/clinica/codex/1c9b56db-fe7f-11e2-a682-95ed0e8e1720.xml">6/8/13</a> </p> </td> <td> <p> 29/10/13 </p> </td> </tr> <tr> <td> <p> <b>Beckman Coulter Life Sciences (US)</b> </p> </td> <td> <p> Flow cytometry business of ReaMetrix India (India) </p> </td> <td> <p> IVD reagents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Beckman-Coulter-expands-flow-cytometry-portfolio-345618?autnID=/contentstore/clinica/codex/679b9da6-fdac-11e2-a682-95ed0e8e1720.xml">5/8/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Beckman-Coulter-expands-flow-cytometry-portfolio-345618?autnID=/contentstore/clinica/codex/679b9da6-fdac-11e2-a682-95ed0e8e1720.xml">5/8/13</a> </p> </td> </tr> <tr> <td> <p> <b>Novadaq Technologies (US)</b> </p> </td> <td> <p> Digirad's Trapper surgical imaging technology and disposable probe </p> </td> <td> <p> Surgery (imaging of sentinal lymph nodes and tumours for resection) </p> </td> <td> <p> $2m upfront, $1m milestones </p> </td> <td> <p> 1/8/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>July</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Trinity Biotech (Ireland)</b> </p> </td> <td> <p> Immco Diagnostics (US) </p> </td> <td> <p> In vitro diagnostics (autoimmune testing) </p> </td> <td> <p> $32.75m </p> </td> <td> <p> 31/7/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Kinetic Concepts (US)</b> </p> </td> <td> <p> Systagenix (UK) </p> </td> <td> <p> Wound care </p> </td> <td> <p> $485m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Kinetic-Concepts-continues-wound-care-diversification-with-Systagenix-buy-345381?autnID=/contentstore/clinica/codex/0196e369-f928-11e2-a682-95ed0e8e1720.xml">30/7/13</a> </p> </td> <td> <p> 28/10/13 </p> </td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> Advanced Liquid Logic (US) </p> </td> <td> <p> Molecular diagnostics (next-generation sequencing workflow) </p> </td> <td> <p> Up to $95m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Illumina-shows-strength-in-Q2-buys-microfluidics-firm-345231?autnID=/contentstore/clinica/codex/54ac800b-f453-11e2-a682-95ed0e8e1720.xml">24/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Exosome Diagnostics (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Illumina-shows-strength-in-Q2-buys-microfluidics-firm-345231?autnID=/contentstore/clinica/codex/54ac800b-f453-11e2-a682-95ed0e8e1720.xml">24/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ZOLL Medical (US)</b> </p> </td> <td> <p> Lifebridge Medizintechnik (Germany) </p> </td> <td> <p> Emergency heart-lung support </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Zoll-gains-portable-heart-lung-machine-tech-with-Lifebridge-buy-345076">17/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ThermoGenesis (US)</b> </p> </td> <td> <p> TotipotentRx (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed (merger to become Cesca Therapeutics) </p> </td> <td> <p> 16/7/13 </p> </td> <td> <p> 21/1/14 </p> </td> </tr> <tr> <td> <p> <b>Abbott (US)</b> </p> </td> <td> <p> OptiMedica (US) </p> </td> <td> <p> Ophthalmology (femtosecond laser for cataract surgery) </p> </td> <td> <p> $250m plus $150m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Abbott-splashes-cash-as-lukewarm-Q2-looms-345036">16/7/13</a> </p> </td> <td> <p> 19/8/13 </p> </td> </tr> <tr> <td> <p> <b>Abbott (US)</b> </p> </td> <td> <p> IDEV Technologies (US) </p> </td> <td> <p> Stents (peripheral artery disease) </p> </td> <td> <p> $310m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Abbott-splashes-cash-as-lukewarm-Q2-looms-345036">16/7/13 </a> </p> </td> <td> <p> 21/8/13 </p> </td> </tr> <tr> <td> <p> <b>Minnextronix (US)</b> </p> </td> <td> <p> Neurofluidics (US) </p> </td> <td> <p> Neurology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/7/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Leica Biosystems (UK)</b> </p> </td> <td> <p> Kreatech Diagnostics (the Netherlands) </p> </td> <td> <p> Diagnostics/pathology (DNA FISH probes) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Danahers-Leica-steps-into-personalized-medicine-with-Kreatech-buy-344847">11/7/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Danahers-Leica-steps-into-personalized-medicine-with-Kreatech-buy-344847">11/7/13</a> </p> </td> </tr> <tr> <td> <p> <b>Nile Therapeutics (US)</b> </p> </td> <td> <p> Capricor (US) </p> </td> <td> <p> Stem cells </p> </td> <td> <p> N/A (share-based reverse merger) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Nile-buys-Capricor-to-access-cash-diversify-344832">10/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Plato Grup (Turkey) </p> </td> <td> <p> Orthopedic and endoscopy products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Smith-and-Nephew-gobbles-up-more-Turkey-distribution-assets-344828">10/7/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Smith-and-Nephew-gobbles-up-more-Turkey-distribution-assets-344828">10/7/13</a> </p> </td> </tr> <tr> <td> <p> <b>Leica Microsystems (UK)</b> </p> </td> <td> <p> Aotec Instrumentos Cientificos (Brazil) </p> </td> <td> <p> Microscopy and histopathology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 9/7/13 </p> </td> <td> <p> 9/7/13 </p> </td> </tr> <tr> <td> <p> <b>Intertek (UK)</b> </p> </td> <td> <p> Melbourn Scientific (UK) </p> </td> <td> <p> Analysis and development services for healthcare, pharmaceutical and biotech infustries (eg, drug delivery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 9/7/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vention Medical (US)</b> </p> </td> <td> <p> RiverTech Medical (US) </p> </td> <td> <p> Polyimide tubing and coatings for devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 9/7/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Neopharm (Israel)</b> </p> </td> <td> <p> Fresenius's biotech business (Germany) </p> </td> <td> <p> Antibodies for immune supression </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Fresenius-narrows-focus-as-it-sells-biotech-business-344782">9/7/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Fresenius-narrows-focus-as-it-sells-biotech-business-344782">9/7/13</a> </p> </td> </tr> <tr> <td> <p> <b>Thoratec (US)</b> </p> </td> <td> <p> Terumo&rsquo;s DuraHeart II (DH-II) ventricular assist device (US) </p> </td> <td> <p> Cardiology (heart failure support) </p> </td> <td> <p> $13m plus up to $43.5m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Thoratec-nabs-Terumos-heart-pump-device-344654?autnID=/contentstore/clinica/codex/6f655963-e3fd-11e2-b558-b53452bf8004.xml">4/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ArthroCare (US)</b> </p> </td> <td> <p> ENTrigue Surgical (US) </p> </td> <td> <p> Surgery (Minimally-invasive surgery for sinusitis) </p> </td> <td> <p> $45m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ArthroCares-ENTrigue-buy-broadens-sinus-surgery-offerings-344653?autnID=/contentstore/clinica/codex/c4e8680b-e3e4-11e2-b558-b53452bf8004.xml">4/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> CR Bard&rsquo;s electrophysiology business (US) </p> </td> <td> <p> Cardiology (cardiac catheter ablations and diagnosis and treatment of heart arrhythmias) </p> </td> <td> <p> $275m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bostons-275m-CR-Bard-buy-marks-maiden-MandA-deal-in-2013-344651?autnID=/contentstore/clinica/codex/90689544-e3f2-11e2-b558-b53452bf8004.xml">4/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Swtizerland)</b> </p> </td> <td> <p> Constitution Medical Investors (US) </p> </td> <td> <p> In vitro diagnostics (hematology testing) </p> </td> <td> <p> $220m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-sniffs-out-BloodHound-hematology-testing-technology-344614?autnID=/contentstore/clinica/codex/588e7cab-e339-11e2-b558-b53452bf8004.xml">3/7/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ZOLL Medical (US)</b> </p> </td> <td> <p> CoAxia (US) </p> </td> <td> <p> Catheter-based therapies for brain ischemia </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/7/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Dempsey Ventures (US) </b> </p> </td> <td> <p> Moog's Ethox Medical division (US) </p> </td> <td> <p> Lab testing services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/7/13 </p> </td> <td> <p> 1/7/13 </p> </td> </tr> <tr> <td> <p> <b>June</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>LifeLabs Medical Laboratory Services (Canada)</b> </p> </td> <td> <p> CML Healthcare (Canada) </p> </td> <td> <p> Diagnostics services provider </p> </td> <td> <p> Can$1.22bn ($1.16bn) inc Can$255m debt </p> </td> <td> <p> 25/6/13 </p> </td> <td> <p> 1/11/13 </p> </td> </tr> <tr> <td> <p> <b>Digital Angel (US)</b> </p> </td> <td> <p> VeriTeQ Acquisition (US) </p> </td> <td> <p> Medical device identification and dosimeter technology for radiation therapy </p> </td> <td> <p> 4.1m Digital Angel shares </p> </td> <td> <p> 25/6/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Certain mammography assets from Rayence (South Korea) </p> </td> <td> <p> Diagnostic imaging (mammography) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-continues-bolt-on-strategy-with-Korean-mammography-acquisition-344328">24/6/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MicroPort Medical (China)</b> </p> </td> <td> <p> Wright Medical's OrthoRecon business (US) </p> </td> <td> <p> Orthopedics (hip and knee implants) </p> </td> <td> <p> $290m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Could-Wrights-all-out-extremities-strategy-attract-buyers-344248">20/6/13</a> </p> </td> <td> <p> 9/1/14 </p> </td> </tr> <tr> <td> <p> <b>Techne (US)</b> </p> </td> <td> <p> Bionostics (US) </p> </td> <td> <p> In vitro diagnostics (quality control devices) </p> </td> <td> <p> $104m </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/ivds/Techne-expands-hematology-offering-with-104m-Bionostics-buy-344237">20/6/13</a> </p> </td> <td> <p> 22/7/13 </p> </td> </tr> <tr> <td> <p> <b>Halifax Group (US)</b> </p> </td> <td> <p> Envision Pharma (UK) </p> </td> <td> <p> Communication for pharma, biotech and device companies </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/6/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Teva Pharmaceuticals (Israel)</b> </p> </td> <td> <p> MicroDose Therapeutx (US) </p> </td> <td> <p> Pharmaceuticals and drug delivery (inhalation tech for lung diseases and infection) </p> </td> <td> <p> $40m plus $125m milestones </p> </td> <td> <p> 17/6/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Life Technologies (US)</b> </p> </td> <td> <p> Life Science Korea (Korea) </p> </td> <td> <p> In vitro diagnostics (instruments) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Life-continues-Korean-expansion-344110">14/6/13</a> </p> </td> <td> <p> 14/6/13 </p> </td> </tr> <tr> <td> <p> <b>RTI Biologics (US)</b> </p> </td> <td> <p> Pioneer Surgical Technology (US) </p> </td> <td> <p> Orthopedics </p> </td> <td> <p> $130m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/RTI-diversifies-into-non-biologics-ortho-344097">14/6/13</a> </p> </td> <td> <p> 16/7/13 </p> </td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Zonare Medical Systems (US) </p> </td> <td> <p> Diagnostic imaging (ultrasound) </p> </td> <td> <p> $105m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Mindray-acquires-high-end-ultrasound-firm-gets-co-CEO-344072">13/6/13</a> </p> </td> <td> <p> 17/7/13 </p> </td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Ultimate Medical (Australia) </p> </td> <td> <p> Airway management </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/6/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> Eon Surgical (Israel) </p> </td> <td> <p> Surgery (microlaparoscopic surgery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Teleflex-bets-on-microlaparoscopy-with-Eon-buy-343966">10/6/13</a> </p> </td> <td> <p> 10/6/13 </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Normed Medizin-Technik (Germany) </p> </td> <td> <p> Orthopedics (trauma and extremities) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-scores-double-whammy-with-Normed-343782?autnID=/contentstore/clinica/codex/de7860b6-cde2-11e2-8b87-5fa2cac32ca8.xml">5/6/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>May</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Nippon Contact Lens (Japan)</b> </p> </td> <td> <p> The Cooper Companies' contact lens business Aime (Japan) </p> </td> <td> <p> Ophthalmology (hard contact lenses) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 31/5/13 </p> </td> <td> <p> 7/11/13 </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Unisyn Medical Technologies&rsquo; transactional business (US) </p> </td> <td> <p> Ultrasound (repair and servicing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-bolsters-over-performing-ultrasound-biz-with-Unisyn-buy-343664?autnID=/contentstore/clinica/codex/1da659d2-c9de-11e2-83c7-bf5438253fbe.xml">31/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Uscom (Australia)</b> </p> </td> <td> <p> Pulsecor (New Zealand) </p> </td> <td> <p> Cardiovascular (noninvasive central blood pressure measurement) </p> </td> <td> <p> 5 million Uscom shares </p> </td> <td> <p> 30/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Valeant Pharmaceuticals (Canada)</b> </p> </td> <td> <p> Bausch + Lomb (US) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> $8.7bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Valeant-confirms-8.7bn-purchase-of-Bausch--Lomb-343542?autnID=/contentstore/clinica/codex/4913c421-c771-11e2-83c7-bf5438253fbe.xml">28/5/13</a> </p> </td> <td> <p> 6/8/13 </p> </td> </tr> <tr> <td> <p> <b>BTG (UK)</b> </p> </td> <td> <p> EKOS (US) </p> </td> <td> <p> Drug delivery (catheter-based for treatment of blood clots) </p> </td> <td> <p> $180m plus $40m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/BTG-aims-for-billion-dollar-interventional-business-with-double-buy-343502?autnID=/contentstore/clinica/codex/95102270-c44b-11e2-83c7-bf5438253fbe.xml">24/5/13</a> </p> </td> <td> <p> 5/7/13 </p> </td> </tr> <tr> <td> <p> <b>BTG (UK)</b> </p> </td> <td> <p> Targeted Therapies division of Nordion (Canada) </p> </td> <td> <p> Oncology (radioactive beads for liver cancer treatment) </p> </td> <td> <p> $200m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/BTG-aims-for-billion-dollar-interventional-business-with-double-buy-343502?autnID=/contentstore/clinica/codex/95102270-c44b-11e2-83c7-bf5438253fbe.xml">24/5/13</a> </p> </td> <td> <p> 13/7/13 </p> </td> </tr> <tr> <td> <p> <b>Maquet Cardiovascular (US)</b> </p> </td> <td> <p> LAAx (US) </p> </td> <td> <p> Left atrial appendage (LAA) closure devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Maquet-beats-Boston-and-St-Jude-to-US-LAA-market-343446?autnID=/contentstore/clinica/codex/ef7c3b30-c2ed-11e2-83c7-bf5438253fbe.xml">22/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Audax Group (US)</b> </p> </td> <td> <p> Chesapeake IRB (US) </p> </td> <td> <p> Independent review board services to pharmaceutical, biotech and medtech companies </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 21/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Ignyta (US)</b> </p> </td> <td> <p> Actagene Oncology (US) </p> </td> <td> <p> Personalised medicine (genome mining and sequencing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 20/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Concentra's the toxicology and clinical lab business (US) </p> </td> <td> <p> In vitro diagnsotics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quest-keeps-building-lab-offering-with-Concentra-buy-343320?autnID=/contentstore/clinica/codex/a412bca9-bedc-11e2-83c7-bf5438253fbe.xml">17/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Unnamed European private equity firm</b> </p> </td> <td> <p> IBA's Cisbio Bioassays unit (Belgium) </p> </td> <td> <p> Assay development and drug screening </p> </td> <td> <p> &euro;25m ($32.3m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/IBA-sells-bioassays-biz-to-complete-radiotherapy-refocus-343191">14/5/13</a> </p> </td> <td> <p> 18/11/13 </p> </td> </tr> <tr> <td> <p> <b>TriStar Wellness Solutions (US)</b> </p> </td> <td> <p> HemCon Medical Technologies (US) </p> </td> <td> <p> Wound care and bleeding control </p> </td> <td> <p> $3m </p> </td> <td> <p> 13/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Biosensors International (Singapore)</b> </p> </td> <td> <p> Spectrum Dynamics (US/Israel) </p> </td> <td> <p> Imaging (cardiovascular treatment planning) </p> </td> <td> <p> $51m plus undisclosed milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Biosensors-gets-complementary-imaging-tech-with-Spectrum-buy-343113">13/5/13</a> </p> </td> <td> <p> 26/5/13 </p> </td> </tr> <tr> <td> <p> <b>Quidel (US)</b> </p> </td> <td> <p> BioHelix (US) </p> </td> <td> <p> Molecular diagnostics (DNA amplification technology) </p> </td> <td> <p> $10m plus undisclosed milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quidel-speeds-test-development-with-BioHelix-buy-342885">7/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>NuVasive (US)</b> </p> </td> <td> <p> ANC (US) </p> </td> <td> <p> Orthopedics (spinal implants) </p> </td> <td> <p> $4.5m </p> </td> <td> <p> 6/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Analytik Jena (Germany)</b> </p> </td> <td> <p> All assets of insolvent SIRS-Lab (Germany) </p> </td> <td> <p> Molecular diagnostics (for infections eg sepsis) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/5/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Knee Creations (US) </p> </td> <td> <p> Orthopedics (knee) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-fills-treatment-gap-with-Knee-Creations-purchase-342822?autnID=/contentstore/clinica/codex/3175ad86-b3e3-11e2-81a2-85260ee98534.xml">3/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Sushrut Surgicals/Adler Mediequip (India) </p> </td> <td> <p> Orthopedics (trauma) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/SandN-buys-Indian-trauma-biz-as-Q1-in-line-342760">2/5/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>April</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Jawbone (US)</b> </p> </td> <td> <p> BodyMedia (US) </p> </td> <td> <p> Patient monitoring/obesity (weight-monitoring arm bands) </p> </td> <td> <p> Undisclosed (thought to be &gt;$100m) </p> </td> <td> <p> 30/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Ingenuity Systems (US) </p> </td> <td> <p> Bioinformatics for gene sequencing </p> </td> <td> <p> $105m </p> </td> <td> <p> 30/4/13 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Qiagen-buys-into-bioinformatics-lowers-2013-guidance-342642">30/4/13</a> </p> </td> </tr> <tr> <td> <p> <b>Source BioScience (UK)</b> </p> </td> <td> <p> Inverclyde Biologicals (UK) </p> </td> <td> <p> In vitro diagnostics (diagnostic kits and reagents) </p> </td> <td> <p> &pound;1.6m ($2.5m) </p> </td> <td> <p> 30/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Bayer (Germany)</b> </p> </td> <td> <p> Conceptus (US) </p> </td> <td> <p> Contraceptive devices </p> </td> <td> <p> $1.1bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Bayer-shores-up-contraceptive-offering-with-Conceptus-buy-342602">29/4/13</a> </p> </td> <td> <p> 6/6/13 </p> </td> </tr> <tr> <td> <p> <b>Co-Diagnostics (US)</b> </p> </td> <td> <p> Genetic analysis technology from DNA Logix (US) </p> </td> <td> <p> Genetic analysis for clinical, industrial and bio-threat applications </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 26/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MAKO Surgical (US)</b> </p> </td> <td> <p> Stanmore Implants Worldwide's robotic assets (UK) </p> </td> <td> <p> Orthopaedics (robotics for knee replacement surgery) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 22/4/13 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Stanmore-MAKO-foe-no-more-342370">22/4/13</a> </p> </td> </tr> <tr> <td> <p> <b>Sanomedics International Holdings (US)</b> </p> </td> <td> <p> Prime Time Medical (US) </p> </td> <td> <p> Home medical equipment (eg, wheelchairs, diabetic supplies, respiratory products) </p> </td> <td> <p> $3m </p> </td> <td> <p> 18/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Eli Lilly (US)</b> </p> </td> <td> <p> Siemens' PET Alzheimer's imaging agents (Germany) </p> </td> <td> <p> Imaging agents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Lilly-buys-Alzheimers-imaging-technology-from-Siemens-342260?autnID=/contentstore/clinica/codex/4af4b22f-a801-11e2-81a2-85260ee98534.xml">18/4/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Dignity Health's clinical outreach services (US) </p> </td> <td> <p> Diagnostic information services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 17/4/13 </p> </td> <td> <p> 24/6/13 </p> </td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> Life Technologies (UK) </p> </td> <td> <p> Life sciences including genome sequencing </p> </td> <td> <p> $13.6bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Thermo-nabs-Life-Tech-for-13.6bn-342161">16/4/13</a> </p> </td> <td> <p> 3/2/14 </p> </td> </tr> <tr> <td> <p> <b>Biohit (Finland)</b> </p> </td> <td> <p> Euroclone's subsidiary Euroclone Gastro (Italy) </p> </td> <td> <p> Gastrointestinal diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Miraculins (Canada)</b> </p> </td> <td> <p> VeraLight's SCOUT DS (US) </p> </td> <td> <p> Diagnostics (noninvasive diabetes screening) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Life Technologies (UK)</b> </p> </td> <td> <p> KDR Biotech (Korea) </p> </td> <td> <p> Reagents (distributor) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mobidiag (Finland)</b> </p> </td> <td> <p> Genewave (France) and Amplidiag (Finland) </p> </td> <td> <p> Molecular diagnostics (infectious diseases) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Origene Technologies (US)</b> </p> </td> <td> <p> SDIX's life science business (US) </p> </td> <td> <p> Monoclonal antibodies for research and diagnostics </p> </td> <td> <p> $16m </p> </td> <td> <p> 8/4/13 </p> </td> <td> <p> 15/7/13 </p> </td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew (UK)</b> </p> </td> <td> <p> Pr� Cirurgia Especializada (Brazil) </p> </td> <td> <p> Sports medicine, orthopaedic reconstruction and trauma products (distributor) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/SandN-bulks-up-in-Brazil-341753">4/4/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>William Demant (Denmark)</b> </p> </td> <td> <p> Neurelec (France) </p> </td> <td> <p> Cochlear implants </p> </td> <td> <p> &euro;57.5m ($73.9m) </p> </td> <td> <p> 2/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mortara Instrument (US)</b> </p> </td> <td> <p> Cardiac Science's Diagnostic Cardiology product line (US) </p> </td> <td> <p> Cardiology diagnostics (eg ECG) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/4/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>March</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Argon Medical Devices (US)</b> </p> </td> <td> <p> Angiotech Pharmaceuticals' interventional products business (US) </p> </td> <td> <p> Interventional devices (biopsy instruments and catheters) </p> </td> <td> <p> $362.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Angiotech-offloads-interventional-devices-to-Argon-341566">26/3/13</a> </p> </td> <td> <p> 15/4/13 </p> </td> </tr> <tr> <td> <p> <b>Cantel Medical (US)</b> </p> </td> <td> <p> Haemodialysis water business from Siemens' Water Technologies (US) </p> </td> <td> <p> Water purification for dialysis </p> </td> <td> <p> $9m </p> </td> <td> <p> 25/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Terumo BCT (US)</b> </p> </td> <td> <p> Medservice (Poland) </p> </td> <td> <p> Blood banking (distributor of products and services) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 20/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Imaging Acquisition/ Psilos Group Managers (US)</b> </p> </td> <td> <p> Gamma Medica's LumaGEM molecular breast imaging business (US) </p> </td> <td> <p> Diagnostic iamging (breast cancer screening) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 19/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cerner (US)</b> </p> </td> <td> <p> Labotix Automation (US) </p> </td> <td> <p> In vitro diagnostics (automated lab testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 18/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cynosure (US)</b> </p> </td> <td> <p> Palomar Medical Technologies (US) </p> </td> <td> <p> Aesthetic lasers </p> </td> <td> <p> $294m </p> </td> <td> <p> 18/3/13 </p> </td> <td> <p> 24/6/13 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> VertiFlex's interspinous process fusion device (US) </p> </td> <td> <p> Orthopaedics (spinal) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Stryker-strikes-out-on-Neptune-341234?autnID=/contentstore/clinica/codex/71ee9e10-8d8b-11e2-9eec-6b7088def52a.xml">15/3/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>JLL Partners (US)</b> </p> </td> <td> <p> BioClinica and CoreLab Partners (US) </p> </td> <td> <p> Medical imaging management for clinical trials </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cordis (US)</b> </p> </td> <td> <p> Flexible Stenting Solutions (US) </p> </td> <td> <p> Cardiovascular (peripheral arterial disease treatment) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/JandJ-PADs-out-Cordis-offering-341169">14/3/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Cato Software Solutions (Austria) </p> </td> <td> <p> Software for pharmacy medication planning </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 12/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Grifols (Spain)</b> </p> </td> <td> <p> 60% stake in Progenika (Spain) </p> </td> <td> <p> In vitro diagnostics (genomic and proteomic tests) </p> </td> <td> <p> &euro;37m ($45.5m) </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Grifols-pays-37m-for-60-stake-in-IVD-company-Progenika-340970">8/3/13</a> </p> </td> </tr> <tr> <td> <p> <b>New York Imaging Service (US)</b> </p> </td> <td> <p> GXC Imaging Specialists (US) </p> </td> <td> <p> Medical imaging equipment and services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Trans1 (US)</b> </p> </td> <td> <p> Baxano (US) </p> </td> <td> <p> Orthopaedics (spine) </p> </td> <td> <p> $23.6m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Trans1-merger-with-spinal-specialist-Baxano-helps-straighten-out-finances-340533">5/3/13</a> </p> </td> <td> <p> 31/5/13 </p> </td> </tr> <tr> <td> <p> <b>PREMIER Biosoft (US)</b> </p> </td> <td> <p> NuSep's ProteoIQ technology (Australia) </p> </td> <td> <p> In vitro diagnostics (proteomics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>EKF Diagnostics (UK)</b> </p> </td> <td> <p> 360 Genomics (UK) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> &pound;1.6m ($2.4m upfront); up to &pound;8m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/EKF-buys-360-Genomics-for-a-sensible-1.6m-to-move-into-molecular-Dx-340502">4/3/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>QuantuMDx (UK)</b> </p> </td> <td> <p> NorthGene (UK) </p> </td> <td> <p> Molecular diagnostics (paternity testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 4/3/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>February</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Vexim (France)</b> </p> </td> <td> <p> Altavance's technology for the injection of orthopaedic cement in vertebroplasty </p> </td> <td> <p> Orthopaedics (spinal) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 28/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Radiometer Medical (Denmark)</b> </p> </td> <td> <p> Quest Diagnostics' HemoCue business (Sweden) </p> </td> <td> <p> In vitro diagnostics (point-of-care testing) </p> </td> <td> <p> $300m </p> </td> <td> <p> <a href="http://http://www.clinica.co.uk/marketsector/ivds/Quest-finds-buyer-for-HemoCue-biz-in-Radiometer-340264?autnID=/contentstore/clinica/codex/8d1994ac-7f3e-11e2-8a80-65ab9effd2d6.xml">25/2/13</a> </p> </td> <td> <p> 9/4/13 </p> </td> </tr> <tr> <td> <p> <b>Consortium of private equity firms One Rock Capital Partners, Laurel Crown Partners and StoneCreek Capital (US)</b> </p> </td> <td> <p> Hycor's urinalysis business (US) </p> </td> <td> <p> In vitro diagnostics (urinalysis) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Hycor-casts-off-urinalysis-to-focus-on-allergy-and-autoimmune-testing-340189?autnID=/contentstore/clinica/codex/c217ffae-7c1b-11e2-bc5a-5b4d00f567ba.xml">21/2/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sorin (Italy)</b> </p> </td> <td> <p> Alcard Industria Mecanica (Brazil) </p> </td> <td> <p> Cardiac surgery devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Sorin-latest-to-go-Brazilian-with-Alcard-buy-340160?autnID=/contentstore/clinica/codex/9b4a16e8-7b6a-11e2-bc5a-5b4d00f567ba.xml">20/2/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (US)</b> </p> </td> <td> <p> Nfocus Neuromedical (US) </p> </td> <td> <p> Neurovascular (treatment of aneurysms) </p> </td> <td> <p> $72m </p> </td> <td> <p> 19/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cardinal Health (US)</b> </p> </td> <td> <p> AssuraMed (US) </p> </td> <td> <p> Home healthcare supplies </p> </td> <td> <p> $2.07bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Cardinal-Health-boosts-home-healthcare-offering-with-2bn-AssuraMed-purchase-340054?autnID=/contentstore/clinica/codex/edf37d16-76bd-11e2-bc5a-5b4d00f567ba.xml">15/2/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Guided Therapeutics (US)</b> </p> </td> <td> <p> Intellectual property for noninvasive eosophageal cancer detection device from Konica Minolta (Japan) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Neusoft Medical Systems (China)</b> </p> </td> <td> <p> Philips-Neusoft Medical Systems joint venture (China) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Biomedical Structures (US)</b> </p> </td> <td> <p> Modified Polymer Components (US) </p> </td> <td> <p> Biomedical textiles and polymers for OEM devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 5/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stem Cell Therapeutics (Canada)</b> </p> </td> <td> <p> Trillium Therapeutics (Canada) </p> </td> <td> <p> Stem cells </p> </td> <td> <p> $2.85m </p> </td> <td> <p> 4/2/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>January</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>JLL Partners (US)</b> </p> </td> <td> <p> CoreLab Partners (US) </p> </td> <td> <p> Medical imaging and cardiac safety solutions </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 30/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Solta Medical (US)</b> </p> </td> <td> <p> Sound Surgical Technologies (US) </p> </td> <td> <p> Aesthetic surgery (liposuction) </p> </td> <td> <p> $25.5m stock and $5m cash </p> </td> <td> <p> 29/1/13 </p> </td> <td> <p> 27/2/13 </p> </td> </tr> <tr> <td> <p> <b>Fortitude Group (US)</b> </p> </td> <td> <p> Legacy Life Science (US) </p> </td> <td> <p> Airway management during anaesthesia </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Samsung (South Korea)</b> </p> </td> <td> <p> NeuroLogica (US) </p> </td> <td> <p> CT scanning (diagnostic imaging) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Samsung-enters-CT-market-with-NeuroLogica-buy-339482">29/1/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Accelerator Applications (AAA, France)</b> </p> </td> <td> <p> Catalana De Dispensaci�n (Cadisa, Spain) </p> </td> <td> <p> SPECT radiopharmaceuticals </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Accelerator Applications (AAA, France)</b> </p> </td> <td> <p> Barnatron (Spain) </p> </td> <td> <p> PET radiopharmaceuticals </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 29/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Toshiba Medical Systems (Japan)</b> </p> </td> <td> <p> Majority stake in TMST T?bbi Sistemler Pazarlama Ticaret ve Servis (Turkey) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Toshiba-goes-beyond-BRIC-with-majority-stake-in-Turkish-distributor-339443">28/1/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Transcat (US)</b> </p> </td> <td> <p> Cal-Matrix Metrology (Canada) </p> </td> <td> <p> Calibration for medical devices, pharma, life sciences </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 25/1/13 </p> </td> <td> <p> 25/1/13 </p> </td> </tr> <tr> <td> <p> <b>AngioDynamics (US)</b> </p> </td> <td> <p> Microsulis Medical (UK) </p> </td> <td> <p> Microwave ablation for cancer treatment </p> </td> <td> <p> $10m upfront, $5m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/AngioDynamics-buys-Microsulis-assets-following-last-years-investment-339365">24/1/13</a> </p> </td> <td> <p> 1/2/13 </p> </td> </tr> <tr> <td> <p> <b>Life Technologies (US)</b> </p> </td> <td> <p> BAC BV (The Netherlands) </p> </td> <td> <p> Biopharmaceutical research and manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Life-on-the-acquisition-trail-with-protein-purification-buy-in-spite-of-sale-rumours-339318">23/1/13</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Life-on-the-acquisition-trail-with-protein-purification-buy-in-spite-of-sale-rumours-339318">23/1/13</a> </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Trauson (China) </p> </td> <td> <p> Orthopaedics (trauma and spine) </p> </td> <td> <p> $764m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-shoots-for-first-Chinese-acquisition-with-764m-Trauson-offer-339165">17/1/13</a> </p> </td> <td> <p> 1/3/2013 </p> </td> </tr> <tr> <td> <p> <b>GSI Group (US)</b> </p> </td> <td> <p> NDS Surgical Imaging (US) </p> </td> <td> <p> Surgery and diagnostic imaging (OEM surgical and radiology displays) </p> </td> <td> <p> $82.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Laser-tech-specialist-GSI-sharpens-medtech-focus-with-surgical-imaging-purchase-339167">17/1/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>BIT Analytical Instruments (Germany)</b> </p> </td> <td> <p> Source Scientific (US) </p> </td> <td> <p> OEM medical device manufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/1/13 </p> </td> <td> <p> 15/1/13 </p> </td> </tr> <tr> <td> <p> <b>Selah Genomics (US)</b> </p> </td> <td> <p> EnGenCore (US) </p> </td> <td> <p> DNA sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 15/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>BC Technical (US)</b> </p> </td> <td> <p> Genesis Medical Imaging (US) </p> </td> <td> <p> Diagnostic imaging service, refurbished systems and parts </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 13/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Analogic (US)</b> </p> </td> <td> <p> Ultrasonix (Canada) </p> </td> <td> <p> Diagnostic imaging (POC ultrasound) </p> </td> <td> <p> $83m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Analogic-boosts-presence-in-POC-ultrasound-and-emerging-markets-with-Ultrasonix-buy-338956">10/1/13</a> </p> </td> <td> <p> 4/3/2013 </p> </td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> Moleculo (US) </p> </td> <td> <p> Gene sequencing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Illumina-buys-Moleculo-to-plug-longer-read-length-capability-gap-338918?autnID=/contentstore/clinica/codex/8f6d2f6e-5a5a-11e2-87fb-f1a3e14bcfeb.xml">9/1/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Selah Genomics (US)</b> </p> </td> <td> <p> Lab21's South Carolina operations (US) </p> </td> <td> <p> Lab testing/in vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 8/1/13 </p> </td> <td> <p> End of 2012 </p> </td> </tr> <tr> <td> <p> <b>athenahealth (US)</b> </p> </td> <td> <p> Epocrates (US) </p> </td> <td> <p> Mobile support software </p> </td> <td> <p> $293m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/athenahealth-splashes-out-293m-on-mobile-health-firm-Epocrates-338884?autnID=/contentstore/clinica/codex/4facda0e-59a5-11e2-87fb-f1a3e14bcfeb.xml">8/1/13</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Natus Medical (US)</b> </p> </td> <td> <p>The Grass Technologies Product Group (US) </p> </td> <td> <p> Neurodiagnostics </p> </td> <td> <p> $18.6m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Natus-seeks-to-grow-Grass-within-expanded-neurology-business-338869?autnID=/contentstore/clinica/codex/056916b6-598d-11e2-87fb-f1a3e14bcfeb.xml">8/1/13</a> </p> </td> <td> <p> 1/2/13 </p> </td> </tr> <tr> <td> <p> <b>Sarnova (US)</b> </p> </td> <td> <p> DXE Medical (US) </p> </td> <td> <p> Emergency and acute care medical products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 7/1/13 </p> </td> <td> <p> 7/1/13 </p> </td> </tr> <tr> <td> <p> <b>Illumina (US)</b> </p> </td> <td> <p> Verinata Health (US) </p> </td> <td> <p> In vitro diagnostics (prenatal testing) </p> </td> <td> <p> $350m upfront, $100m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Illuminas-NGS-based-prenatal-test-offering-swells-with-Verinata-buy-338847?autnID=/contentstore/clinica/codex/eb99e9f3-58df-11e2-87fb-f1a3e14bcfeb.xml">7/1/13</a> </p> </td> <td> <p> 21/2/13 </p> </td> </tr> <tr> <td> <p> <b>Endochoice (US)</b> </p> </td> <td> <p> Peer Medical (Israel) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 6/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Immucor (US)</b> </p> </td> <td> <p> Hologic's LIFECODES unit (US) </p> </td> <td> <p> In vitro diagnostics (for transplantation) </p> </td> <td> <p> $85m upfront, $10m milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Hologic-offloads-likely-slow-growth-unprofitable-LIFECODES-asset-to-Immucor-338808?autnID=/contentstore/clinica/codex/7468f002-5676-11e2-87fb-f1a3e14bcfeb.xml">4/1/13</a> </p> </td> <td> <p> 22/3/13 </p> </td> </tr> <tr> <td> <p> <b>Helmer Scientific (US)</b> </p> </td> <td> <p> ThermoGenesis's ThermoLine product line (US) </p> </td> <td> <p> Cell therapy (processing, storage and administration) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 3/1/13 </p> </td> <td> <p> 3/1/13 </p> </td> </tr> <tr> <td> <p> <b>Claymount North America (The Netherlands)</b> </p> </td> <td> <p> Advanced Instrument Development (US) </p> </td> <td> <p> X-ray equipment components </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 2/1/13 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Home Care (US)</b> </p> </td> <td> <p> Extrakare (US) </p> </td> <td> <p> Home medical equipment </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 1/1/13&nbsp; </p> </td> <td> <p> 1/1/13 </p> </td> </tr> </table> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 29

Mergers and Acquisitions 2013
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T185753
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT056039
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 29

Mergers and Acquisitions 2013
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

297213
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T185404Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

a1fcb0b4-4aab-4984-9ca0-370c1e940fc0
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T225753Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
